Form 8-K - Current report:
SEC Accession No. 0000950170-24-021109
Filing Date
2024-02-27
Accepted
2024-02-27 16:08:05
Documents
13
Period of Report
2024-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vtyx-20240227.htm   iXBRL 8-K 40811
2 EX-99.1 vtyx-ex99_1.htm EX-99.1 115335
  Complete submission text file 0000950170-24-021109.txt   278521

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vtyx-20240227.xsd EX-101.SCH 24846
14 EXTRACTED XBRL INSTANCE DOCUMENT vtyx-20240227_htm.xml XML 4712
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 24686637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)